Pereira named CEO of Visterra; Biovest comes out of Ch. 11; Missing protein may explain fear;

 @FierceBiotech: ICYMI: Merck's positive Alzheimer's study spotlights BACE race. Article | Follow @FierceBiotech

 @JohnCFierce: In pharma, incremental innovation lives on. Story | Follow @JohnCFierce

 @RyanMFierce: A $30.6M financing for Ayasdi, BigData analytics and discovery for life sciences, energy and other industries. Release | Follow @RyanMFierce

> The former CEO of Amag, Brian Pereira, has taken the helm at Visterra, which is focused on infectious diseases. "I envision Visterra as a company with the potential to deliver multiple products from its novel therapeutic platform, and I look forward to working with the strong team that is in place, so that together we will accelerate opportunities to develop and commercialize innovative medicines," Pereira said in a statement. Release

> Tampa-based Biovest has emerged from Chapter 11 with new management. Carlos Santos is the new CEO. Story

> ThermoGenesis and TotipotentRx Corporation have struck a definitive merger agreement. Release

> Probiodrug AG provided an update on PQ912, in clinical development for the treatment of Alzheimer's disease. Release

Medical Device News

 @FierceMedDev: Boston Scientific, Sorin team up on heart valve. Article | Follow @FierceMedDev

 @MarkHFierce: The FDA approved the first Dx test designed to help diagnose ADHD in children and teens. EEG tech is a core element. Press release | Follow @MarkHFierce

 @DamianFierce: No Synthes, no growth for JNJ's medical devices and diagnostics business. Report | Follow @DamianFierce

> Myriad ups patient assistance as it sues cheaper rivals. Story

> NEA invests $4.3M in Cartiva's joint replacement work. Item

Pharma News

 @FiercePharma: China's corruption watchdogs eye 4 more drugmakers as GSK manager confesses to bribery on TV. More | Follow @FiercePharma

 @CarlyHFierce: NICE says no to Pfizer's Bosulif. Been pretty skeptical about new cancer drugs. Release | Follow @CarlyHFierce

> First Manhattan sues Vivus for 'illegally' delaying shareholder vote. News

> J&J drug sales leap 12%, with Zytiga, Stelara leading growth. Article

Biotech Research News

 @EmilyMFierce: Obesity gene found to regulate hunger hormone. More | Follow @EmilyMFierce

> Researchers unveil largest database of cancer-related genetic variations. News

> Senate committee approves funding increase for NIH in FY 2014. Article

> Sorrento Therapeutics, Israeli university team up to fight hep C. Item

Pharma Manufacturing News

 @EricPFierce: BTG said its Biocompatibles unit had received an FDA warning letter for its plant in Oxford, CT. Article | Follow @EricPFierce

> FDA lays out when plant inspection delays will lead to penalties. Report

> Roche to put $105M into training center. News

> Sanofi starts production on complex dengue vaccine. Article

And Finally… Neuroscientists say that a missing brain protein may explain a pathological sense of fear in mice. More

Suggested Articles

Q32 Bio raised $60 million to push its lead antibody through the clinic and bolster its pipeline and the technology behind it.

Sanofi is teaming up with Merck while AstraZeneca taps Arcus as the future of cancer work is very much made together.

The action follows the FDA’s decision to reject a filing for approval of the JAK1 inhibitor in rheumatoid arthritis due to toxicity concerns.